Amalgamated Bank increased its position in National Health Investors, Inc. (NYSE:NHI) by 10.0% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 5,027 shares of the real estate investment trust’s stock after purchasing an additional 459 shares during the period. Amalgamated Bank’s holdings in National Health Investors were worth $398,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of NHI. Carroll Financial Associates Inc. purchased a new stake in shares of National Health Investors in the 2nd quarter valued at about $158,000. Allegis Investment Advisors LLC purchased a new stake in shares of National Health Investors in the 2nd quarter valued at about $216,000. Teacher Retirement System of Texas lifted its holdings in shares of National Health Investors by 2.0% in the 2nd quarter. Teacher Retirement System of Texas now owns 3,192 shares of the real estate investment trust’s stock valued at $253,000 after purchasing an additional 62 shares during the last quarter. Tudor Investment Corp ET AL purchased a new stake in shares of National Health Investors in the 1st quarter valued at about $262,000. Finally, GAM Holding AG lifted its holdings in shares of National Health Investors by 8.8% in the 2nd quarter. GAM Holding AG now owns 3,327 shares of the real estate investment trust’s stock valued at $263,000 after purchasing an additional 269 shares during the last quarter. 70.67% of the stock is owned by institutional investors and hedge funds.

In other news, insider Kevin Carlton Pascoe sold 2,000 shares of the stock in a transaction dated Thursday, August 24th. The shares were sold at an average price of $79.80, for a total transaction of $159,600.00. Following the transaction, the insider now owns 21,228 shares of the company’s stock, valued at $1,693,994.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 5.19% of the company’s stock.

Shares of National Health Investors, Inc. (NYSE:NHI) opened at 77.42 on Friday. The stock has a 50 day moving average price of $79.10 and a 200 day moving average price of $76.61. The stock has a market capitalization of $3.17 billion, a P/E ratio of 19.88 and a beta of 0.56. National Health Investors, Inc. has a 12-month low of $66.31 and a 12-month high of $81.21.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 EPS for the quarter, missing the consensus estimate of $1.29 by ($0.36). National Health Investors had a return on equity of 12.56% and a net margin of 59.24%. The company had revenue of $69.84 million for the quarter, compared to the consensus estimate of $67.68 million. During the same period in the previous year, the business posted $1.22 EPS. The business’s revenue for the quarter was up 14.1% on a year-over-year basis. On average, equities analysts anticipate that National Health Investors, Inc. will post $3.85 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, November 10th. Stockholders of record on Friday, September 29th will be given a dividend of $0.95 per share. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $3.80 annualized dividend and a dividend yield of 4.91%. National Health Investors’s payout ratio is 97.69%.

Several research firms have recently weighed in on NHI. BidaskClub downgraded National Health Investors from a “hold” rating to a “sell” rating in a report on Wednesday, August 9th. ValuEngine downgraded National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, June 13th. Zacks Investment Research downgraded National Health Investors from a “buy” rating to a “hold” rating in a report on Wednesday, September 6th. Mizuho reissued a “hold” rating and issued a $82.00 target price on shares of National Health Investors in a report on Wednesday. Finally, Stifel Nicolaus boosted their target price on National Health Investors from $80.00 to $82.00 and gave the company a “buy” rating in a report on Wednesday, June 21st. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $80.20.

ILLEGAL ACTIVITY WARNING: This news story was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright law. The legal version of this news story can be read at https://www.thecerbatgem.com/2017/10/08/amalgamated-bank-boosts-stake-in-national-health-investors-inc-nhi.html.

National Health Investors Profile

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Stock Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related stocks with our FREE daily email newsletter.